Skip to main content
OpenTrials
Completed

NCT Number: NCT03523559

Genetic and Histopathologic Characteristics of Interstitial Cystitis

Genetic and Histopathologic Characteristics of Interstitial Cystitis

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Samsung Medical Center, Sungkyunkwan University School of Medicine

Seoul, 135-710, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female aged 19 yrs or greater
  • Patients diagnosed with Hunner lesion in Interstitial cystitis and who is scheduled to undergo transurethral resection
  • Patients diagnosed with Bladder cancer and who is scheduled to undergo cystectomy

Exclusion criteria

  • Male and female under aged 20 yrs
  • A person whose area of bladder cancer is larger than that of the normal area
  • A person who is going to have a cystectomy after chemotherapy on bladder cancer

Treatment and study plan

bladder tissue of Interstitial Cystitis and normal bladder tissue

Genetic

Obtain the bladder tissue of Interstitial Cystitis and normal during the operation

Primary outcomes

  1. Genetic differences between ulcer and non-ulcer of bladder in Interstitial Cystitis

    Time frame: 30days

  2. Genetic differences between bladder tissue of Interstitial Cystitis and normal bladder tissue

    Time frame: 30days

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Registry information

Important dates

Study start
2018
Primary completion
2023
Study completion
2024
First posted
May 14, 2018
Registry last updated
Oct 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.